Clinical Trial Update: TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating TA-8995 for mild dyslipidemia (TULIP) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• TA-8995

Snippet

Sponsor: Xention Ltd | Conditions: Dyslipidemia | Phase 2 | Status: COMPLETED